doi: 10.4103/0973-6247.83255.
Thrombotic thrombocytopenic purpura treated with vincristine in a Jehovah's witness
Affiliations
- PMID: 21897605
- PMCID: PMC3159256
- DOI: 10.4103/0973-6247.83255
Item in Clipboard
Thrombotic thrombocytopenic purpura treated with vincristine in a Jehovah's witness
Asian J Transfus Sci.
2011 Jul.
No abstract available
Similar articles
-
Successful management of thrombotic thrombocytopenic purpura in a Jehovah's Witness without plasma exchange.J Clin Apher. 2015 Feb;30(1):46-9. doi: 10.1002/jca.21325. Epub 2014 Apr 30. J Clin Apher. 2015. PMID: 24782109
-
Therapeutic modalities in thrombotic thrombocytopenic purpura management among Jehovah's Witness patients: A review of reported cases.Transfus Apher Sci. 2023 Aug;62(4):103706. doi: 10.1016/j.transci.2023.103706. Epub 2023 Mar 21. Transfus Apher Sci. 2023. PMID: 36990894 Review.
-
Successful management of a Jehovah's Witness with thrombotic thrombocytopenic purpura unwilling to be treated with therapeutic plasma exchange.J Clin Apher. 2007;22(6):330-2. doi: 10.1002/jca.20150. J Clin Apher. 2007. PMID: 18080270
-
Survival of a Jehovah's Witness with thrombotic thrombocytopenic purpura without using plasma: A case report and review of the literature.J Clin Apher. 2019 Oct;34(5):623-630. doi: 10.1002/jca.21710. Epub 2019 May 22. J Clin Apher. 2019. PMID: 31116457 Review.
-
Immune-mediated thrombotic thrombocytopenic purpura in a Jehovah's Witness - Effectiveness of incorporating extracorporeal immunoadsorption to caplacizumab, steroids and rituximab.Clin Case Rep. 2022 May 20;10(5):e05902. doi: 10.1002/ccr3.5902. eCollection 2022 May. Clin Case Rep. 2022. PMID: 35600013 Free PMC article.
Cited by
-
Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience.Balkan Med J. 2018 Nov 15;35(6):417-421. doi: 10.4274/balkanmedj.2017.1215. Epub 2018 Jul 3. Balkan Med J. 2018. PMID: 29966997 Free PMC article.
-
Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura.J Thromb Haemost. 2020 Oct;18(10):2503-2512. doi: 10.1111/jth.15009. Epub 2020 Sep 11. J Thromb Haemost. 2020. PMID: 32914535 Free PMC article.
-
Successful Management of Thrombotic Thrombocytopenic Purpura in a Jehovah's Witness: An Individualized Approach With Joint Decision-Making.J Patient Exp. 2020 Feb;7(1):8-11. doi: 10.1177/2374373519829902. Epub 2019 Feb 14. J Patient Exp. 2020. PMID: 32128364 Free PMC article.
-
Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management.J Clin Med. 2021 Feb 2;10(3):536. doi: 10.3390/jcm10030536. J Clin Med. 2021. PMID: 33540569 Free PMC article. Review.
References
-
- Sadler JE, Moake JL, Miyata T, George JN. Recent advances in thrombotic thromobocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2004;1:407–23. - PubMed
-
- Verbeke L, Delforge M, Dierickx D. Current insight into thrombotic thrombocytopenic purpura. Blood Coagul Fibrinolysis. 2010;21:3–10. - PubMed
-
- Rock G, Porto C, Bobbio-Pallavicini E. Thrombotic thromobocytopenic purpura treatment in the year 2000. Haemotologica. 2000;85:410–9. - PubMed
-
- Patel A, Patel H, Patel A. Thrombotic thrombocytopenic purpura: The masquerader. Southern Med J. 2009;102:504–9. - PubMed
-
- Ferrara F, Annunziata M, Pollio F, Palmieri S, Copia C, Mele G, et al. Vincristine as treatment for recurrent episodes of thrombotic thrombocytopenic purpura. Ann Hematol. 2002;81:7–10. - PubMed
